Epidemiology of Cancer Healthcare & Outcomes (ECHO)
The ECHO research group is a new multi-disciplinary team established in 2015, dedicated to understanding variations in intervals and pathways to the diagnosis of cancer, cancer outcomes, and cancer patient experience.
Our research spans several lines of enquiry:
- Examining patient and healthcare factors responsible for diagnostic delay before or after presentation, signals of missed diagnostic opportunities and variation in treatment patterns.
- Describing variation in cancer patient experience and ways by which it can be measured more effectively
- Analysing inequalities (between patients and healthcare organisations) to reveal potential responsible mechanisms to better target public health or healthcare interventions
Current collaborations include the University of Cambridge, University of Newcastle, University of Exeter, University of Leeds, London School of Hygiene & Tropical Medicine, and the University of Surrey.
Our work is supported by Cancer Research UK, Macmillan Cancer Support, the BMA TP Gunton grant, and the Department of Health Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis.
Together with the Cancer Communication & Screening research group, the ECHO group run the BSH Cancer screening, help-seeking and prevention PubMed Commons Journal Club.
This group is led by Professor Yoryos Lyratzopoulos: y.lyratzopoulos[at]ucl.ac.uk.
Ongoing research projects
- Theoretical contributions in the field of diagnostic timeliness or delay in cancer
- Variation in markers and measures of diagnostic intervals
- Understanding cancer patient experience
- Epidemiology of diagnosis of cancer as an emergency
- Help-seeking for possible cancer symptoms after a previous 'all clear' diagnosis
- Opportunities for earlier diagnosis of gastro-intestinal cancers